Can Benadryl (diphenhydramine) be used to treat akathisia?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 2, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Benadryl for Akathisia

Benadryl (diphenhydramine) is effective for treating new-onset akathisia, particularly when caused by antidopaminergic agents like prochlorperazine (Compazine) or metoclopramide, but it is not recommended as prophylaxis or first-line treatment for antipsychotic-induced akathisia. 1, 2

Context-Dependent Effectiveness

The utility of diphenhydramine varies significantly based on the causative agent and timing:

For Antiemetic-Induced Akathisia (Compazine, Metoclopramide)

  • Diphenhydramine 25-50 mg parenterally is often effective for new-onset akathisia from antidopaminergic antiemetics like prochlorperazine, working through anticholinergic and antihistaminic properties to counteract dopamine blockade. 1, 2
  • For pediatric patients, use 1-2 mg/kg per dose (maximum 50 mg) administered parenterally. 3
  • The American Academy of Child and Adolescent Psychiatry recommends diphenhydramine as an effective treatment for new-onset Compazine-induced akathisia, though it should be considered alongside dose reduction as first-line management. 1

For Antipsychotic-Induced Akathisia

  • Diphenhydramine is NOT recommended as first-line treatment for antipsychotic-induced akathisia. 4, 5
  • Beta-blockers (propranolol 10-30 mg two to three times daily) and mirtazapine (7.5-15 mg once daily) have the strongest evidence for antipsychotic-induced akathisia. 1, 4, 5
  • Anticholinergic agents like diphenhydramine may provide symptomatic relief but are considered inferior to beta-blockers or mirtazapine. 4, 6

Critical Distinction: Treatment vs. Prophylaxis

Diphenhydramine should NOT be used routinely as prophylaxis against metoclopramide-induced akathisia. 7

  • A randomized trial demonstrated that prophylactic diphenhydramine 25 mg provided no benefit in preventing akathisia when metoclopramide was administered intravenously over 15 minutes (12% akathisia rate in both diphenhydramine and placebo groups). 7
  • The ASCO guideline update explicitly removed diphenhydramine from antiemetic regimens, noting that with high-dose metoclopramide rarely used, the rationale for prophylactic diphenhydramine no longer exists. 8

Practical Treatment Algorithm

When akathisia develops:

  1. First priority: Reduce or discontinue the offending agent if clinically feasible, as this addresses the root cause most reliably. 1

  2. For antiemetic-induced akathisia (Compazine, metoclopramide):

    • Administer diphenhydramine 25-50 mg IV/IM for adults 1, 2
    • For children: 1-2 mg/kg per dose (maximum 50 mg) 3
    • Expect onset within several minutes with effects lasting 4-6 hours 3
  3. For antipsychotic-induced akathisia:

    • First-line: Propranolol 10-30 mg two to three times daily 1, 5
    • Alternative: Mirtazapine 7.5-15 mg once daily 4, 5
    • Benzodiazepines (clonazepam) for symptomatic relief 1, 5
    • Anticholinergics like diphenhydramine only if other options fail or are contraindicated 6

Important Caveats

  • Monitor for excessive sedation when combining diphenhydramine with other sedating medications like prochlorperazine, requiring careful assessment of respiratory status and consciousness level. 3
  • Other adverse effects include hypotension, dizziness, blurred vision, dry mouth, and urinary retention. 3
  • For patients with contraindications to beta-blockers (asthma, bradycardia, hypotension), consider alternative antiemetics like ondansetron rather than relying on diphenhydramine for akathisia management. 3, 4
  • Diphenhydramine is most effective when akathisia is recognized and treated early in its course. 2

References

Guideline

Treatment of Compazine-Induced Akathisia

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Akathisia: the syndrome of motor restlessness.

American family physician, 1987

Guideline

Diphenhydramine Dosing for Prevention of Prochlorperazine-Induced Akathisia in Children

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.